Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Notes Payables (2019 - 2025)

Volitionrx (VNRX) has disclosed Notes Payables for 4 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Notes Payables changed N/A year-over-year to $1.5 million, compared with a TTM value of $1.5 million through Sep 2025, changed N/A, and an annual FY2012 reading of $52860.0, changed N/A over the prior year.
  • Notes Payables was $1.5 million for Q3 2025 at Volitionrx, up from $166522.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $1.5 million in Q3 2025 and bottomed at $166522.0 in Q2 2025.